Home

Melissa M. Tomkiel

CIK 1859484 · Co-CEO and General Counsel · last filed 2026-06-18

Melissa M. Tomkiel is a Co-CEO and General Counsel who has filed 60 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing shows the insider had shares withheld for taxes covering $174.5K of SRTA on Jun 18, 2026. Across all open-market trades the lifetime net is −$2.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.50M

Companies

3

Total Filings

60

Lifetime Open-Market Net

-$2.54M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SRTA Co-CEO and General Counsel 1,892,774 $5.02 $9.50M -$174.5K 2 2026-06-18
Strata Critical Medical, Inc. (SRTAW) Delisted Co-CEO and General Counsel 2,244,254 $0.00 $1.3K $0 9 2026-04-27
Strata Critical Medical, Inc. (BLDEW) Delisted President and General Counsel 1,169,334 $0.18 $209.8K -$2.37M 39 2025-08-07

Recent Filings

60 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-18 SRTA Tax (F) −29,730 -$174.5K EDGAR
2026-06-10 SRTA Sell (S) −29,730 -$174.5K EDGAR
2026-04-27 Strata Critical Medical, Inc. (SRTAW) Delisted Mixed +308,514 -$1.58M EDGAR
2026-03-10 Strata Critical Medical, Inc. (SRTAW) Delisted Tax (F) −29,372 -$133.3K EDGAR
2026-01-05 Strata Critical Medical, Inc. (SRTAW) Delisted Exer (M) +276,960 $49.9K EDGAR
2025-12-12 Strata Critical Medical, Inc. (SRTAW) Delisted Tax (F) −34,018 -$149.0K EDGAR
2025-11-12 Strata Critical Medical, Inc. (SRTAW) Delisted Exer (M) +27,778 $5.0K EDGAR
2025-11-05 Strata Critical Medical, Inc. (SRTAW) Delisted Mixed +102,270 -$536.5K EDGAR
2025-10-23 Strata Critical Medical, Inc. (SRTAW) Delisted Exer (M) +55,556 $10.0K EDGAR
2025-10-14 Strata Critical Medical, Inc. (SRTAW) Delisted Exer (M) +55,555 $10.0K EDGAR
Showing 1–10 of 60
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.